Covered recipient · General Payments record
MATTHEW G VICINANZO
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$821.92
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $292.17 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $292.17 | 21 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.37 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194884 | CMS |
| Amgen Inc. | $16.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194903 | CMS |
| Amgen Inc. | $16.68 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194890 | CMS |
| Amgen Inc. | $13.43 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194899 | CMS |
| Amgen Inc. | $15.15 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194894 | CMS |
| Amgen Inc. | $16.15 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194920 | CMS |
| Amgen Inc. | $9.75 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194907 | CMS |
| Amgen Inc. | $3.97 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194911 | CMS |
| Amgen Inc. | $15.22 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194916 | CMS |
| Amgen Inc. | $16.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194931 | CMS |
| Amgen Inc. | $14.79 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194922 | CMS |
| Amgen Inc. | $5.06 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194926 | CMS |
| Amgen Inc. | $14.35 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194936 | CMS |
| Amgen Inc. | $16.25 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194940 | CMS |
| Amgen Inc. | $16.97 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194948 | CMS |
| Amgen Inc. | $19.40 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194944 | CMS |
| Amgen Inc. | $5.90 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194951 | CMS |
| Amgen Inc. | $19.65 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194955 | CMS |
| Amgen Inc. | $21.55 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194959 | CMS |
| Amgen Inc. | $14.58 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194966 | CMS |
| Amgen Inc. | $7.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116194963 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.